Home Cart Sign in  
Chemical Structure| 173039-10-6 Chemical Structure| 173039-10-6

Structure of 2-PMPA
CAS No.: 173039-10-6

Chemical Structure| 173039-10-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

2-PMPA is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM.

Synonyms: 2-(Phosphonomethyl)pentanedioic acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 2-PMPA

CAS No. :173039-10-6
Formula : C6H11O7P
M.W : 226.12
SMILES Code : OC(=O)CCC(CP(O)(O)=O)C(O)=O
Synonyms :
2-(Phosphonomethyl)pentanedioic acid
MDL No. :MFCD00940167
InChI Key :ISEYJGQFXSTPMQ-UHFFFAOYSA-N
Pubchem ID :10130754

Safety of 2-PMPA

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice C4-2 prostate cancer xenograft model Intravenous injection 3 mg/kg Single dose Evaluate the preferential delivery of 2-PMPA to salivary glands and kidneys by JHU-2545, showing significantly higher 2-PMPA exposure in kidneys and salivary glands with minimal effect on tumor. Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1631-1641
Mice DSS-induced colitis model and IL-10−/− spontaneous colitis model Intraperitoneal injection 100 mg/kg Once daily for 7 days (DSS model) or 3 weeks (IL-10−/− model) 2-PMPA significantly improved disease activity index, colon weight, colon length, and histopathological scores in both DSS-induced colitis and IL-10?/? spontaneous colitis models. JCI Insight. 2016 Aug 4;1(12):e88634
Rats Cocaine self-administration and brain-stimulation reward model Intraperitoneal injection 10, 30, 100 mg/kg Single administration, 30 minutes pretreatment 2-PMPA significantly inhibited cocaine self-administration and cocaine-enhanced brain-stimulation reward, and these effects were blocked by the mGlu2/3 receptor antagonist LY341495. Neuropharmacology. 2010 Jan;58(1):304-13
Mice TNBS-induced colitis model Enema administration 2.5 mg/mL Once daily for 3 days To evaluate the therapeutic effect of 2-PMPA in the TNBS-induced colitis model, results showed that 2-PMPA significantly ameliorated macroscopic and microscopic symptoms of colitis. J Control Release. 2017 Oct 10;263:132-138
BALB/c nude mice LS174T-PSMA and LNCaP xenograft models Intravenous injection 50 nmol Single injection To evaluate the inhibitory effect of 2-PMPA on renal uptake and its impact on tumor/kidney radioactivity ratios Theranostics. 2016 Apr 12;6(6):849-61

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.42mL

0.88mL

0.44mL

22.11mL

4.42mL

2.21mL

44.22mL

8.84mL

4.42mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories